Skip to main content
. 2021 Apr 23;16(4):e0250530. doi: 10.1371/journal.pone.0250530

Table 2. Demographic and clinical characteristics.

Whole cohort N = 541 Stratified by HPV N = 528
HPV-N = 378 HPV+N = 150
Variable N (%) N (%) N (%) p-Value
Age [Mean (std)] Years 53.5 (10.4) 52.7 (10.1) 55.5 (10.6) 0.004
Age 21–40 42 (8%) 32 (8%) 9 (6%) 0.18
41–60 358 (66%) 255 (67%) 94 (63%)
61 to 86 141 (26%) 91 (24%) 47 (31%)
Stage 1 29 (5%) 22 (6%) 7 (5%) 0.40
2 68 (13%) 47 (12%) 20 (13%)
3 84 (16%) 61 (16%) 16 (11%)
4 359 (66%) 248 (66%) 106 (71%)
T-stage 1 64 (12%) 47 (12%) 15 (10%) 0.008
2 187 (35%) 117 (31%) 69 (46%)
3 108 (20%) 75 (20%) 27 (18%)
4 181 (34%) 139 (37%) 38 (26%)
N-stage 0 169 (31%) 122 (32%) 41 (28%) 0.22
1 77 (14%) 59 (16%) 16 (11%)
2 246 (46%) 165 (44%) 77 (52%)
3 48 (9%) 32 (8%) 15 (10%)
Disease Site Soft Palate 132 (24%) 111 (29%) 19 (13%) <0.0001
Tongue Base 90 (17%) 67 (18%) 22 (15%)
Tonsil 315 (58%) 196 (52%) 109 (73%)
Oropharynx, Other 4 (1%) 4 (1%) 0 (0%)
Initial Treatment Chemoradiation 403 (75%) 279 (75%) 114 (77%) 0.29
Radiation 89 (17%) 59 (16%) 27 (18%)
Surgery 43 (8%) 35 (9%) 8 (5%)
Risk Factors
Alcohol Yes 278 (51%) 213 (56%) 56 (37%) <0.0001
Smoke Yes 448 (83%) 339 (90%) 97 (65%) <0.0001
Betel Quid Yes 349 (65%) 285 (75%) 53 (35%) <0.0001
Alcohol and/or Smoke and/or Betel Quid Yes 468 (87%) 351 (93%) 105 (70%) <0.0001
Outcomes
Death 310 237 65
Recurrence 99 82 12
Neck Recurrence 82 67 13
Metastasis 55 39 13

HPV positivity is defined as HPV DNA-positive and/or p16-positive. p-values derived from t-test (continuous measures) or Chi-square test (categorical) by HPV status, missing values were excluded. TNM classification, according to the 7th AJCC staging edition: "T" (T classification), "N" (N classification), and "Stage" (overall stage). Because all cases were presented with no metastasis (M0), there is no heading for M. The individual variables "Alcohol", "Smoke, and "Betel Quid" were not adjusted for exposure to the other two risk factors.